Integrated Diagnostics Holdings plc (IDGXF)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 504.94 Million EGP | 194.9% |
| 2022 | -532.08 Million EGP | 32.93% |
| 2021 | -793.38 Million EGP | -1550.99% |
| 2020 | -48.05 Million EGP | -233.85% |
| 2019 | 35.9 Million EGP | 118.4% |
| 2018 | -195.17 Million EGP | 62.07% |
| 2017 | -514.49 Million EGP | 3.28% |
| 2016 | -531.92 Million EGP | -69.86% |
| 2015 | -313.14 Million EGP | -24.95% |
| 2014 | -250.62 Million EGP | 3.97% |
| 2013 | -260.99 Million EGP | 20.72% |
| 2012 | -329.21 Million EGP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 476.41 Million EGP | -13.95% |
| 2024 Q1 | 553.63 Million EGP | 68.67% |
| 2023 Q4 | 328.24 Million EGP | -10.45% |
| 2023 Q1 | -392.49 Million EGP | 26.24% |
| 2023 FY | 504.94 Million EGP | 194.9% |
| 2023 Q2 | -367.63 Million EGP | 6.33% |
| 2023 Q3 | 366.56 Million EGP | 199.71% |
| 2022 Q2 | -1.58 Billion EGP | -39.99% |
| 2022 Q4 | -532.08 Million EGP | -19.35% |
| 2022 Q3 | -445.83 Million EGP | 71.83% |
| 2022 FY | -532.08 Million EGP | 32.93% |
| 2022 Q1 | -1.13 Billion EGP | -42.51% |
| 2021 Q4 | -793.38 Million EGP | 6.62% |
| 2021 Q3 | -849.65 Million EGP | 27.69% |
| 2021 FY | -793.38 Million EGP | -1550.99% |
| 2021 Q2 | -1.17 Billion EGP | 0.0% |
| 2020 Q1 | 630.5 Million EGP | 1656.15% |
| 2020 Q4 | -48.05 Million EGP | 0.0% |
| 2020 Q2 | 13.22 Million EGP | -97.9% |
| 2020 FY | -48.05 Million EGP | -233.85% |
| 2019 Q2 | 213.65 Million EGP | -67.26% |
| 2019 FY | 35.9 Million EGP | 118.4% |
| 2019 Q4 | 35.9 Million EGP | 0.0% |
| 2019 Q1 | 652.51 Million EGP | 434.33% |
| 2018 Q3 | 351.91 Million EGP | 345.67% |
| 2018 Q4 | -195.17 Million EGP | -155.46% |
| 2018 FY | -195.17 Million EGP | 62.07% |
| 2018 Q1 | -75.61 Million EGP | 85.3% |
| 2018 Q2 | -143.24 Million EGP | -89.45% |
| 2017 Q4 | -514.49 Million EGP | 0.0% |
| 2017 Q1 | -185.81 Million EGP | 65.07% |
| 2017 Q2 | -260.69 Million EGP | -40.3% |
| 2017 FY | -514.49 Million EGP | 3.28% |
| 2016 Q1 | -349.24 Million EGP | -11.53% |
| 2016 FY | -531.92 Million EGP | -69.86% |
| 2016 Q2 | -392.48 Million EGP | -12.38% |
| 2016 Q4 | -531.92 Million EGP | -230.83% |
| 2016 Q3 | 406.59 Million EGP | 203.6% |
| 2015 Q1 | -146.47 Million EGP | 41.56% |
| 2015 FY | -313.14 Million EGP | -24.95% |
| 2015 Q4 | -313.14 Million EGP | 0.0% |
| 2015 Q2 | -196.34 Million EGP | -34.05% |
| 2014 Q4 | -250.62 Million EGP | 0.0% |
| 2014 Q1 | 264.69 Million EGP | 201.22% |
| 2014 FY | -250.62 Million EGP | 3.97% |
| 2013 Q4 | -261.51 Million EGP | 0.0% |
| 2013 FY | -260.99 Million EGP | 20.72% |
| 2012 FY | -329.21 Million EGP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -22789.665% |
| Arrayit Corporation | 1.05 Million USD | -47735.882% |
| Atlantic International Corp. | 236.49 Thousand USD | -213411.434% |
| Biocept, Inc. | -788 Thousand USD | 64179.442% |
| Bioqual, Inc. | -12 Million USD | 4305.393% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -2220516.562% |
| DermTech, Inc. | 17.65 Million USD | -2760.398% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 188.201% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 6944.954% |
| iMD Companies, Inc. | 1.11 Million USD | -45149.544% |
| IDenta Corp. | 524.85 Thousand USD | -96107.312% |
| Interpace Biosciences, Inc. | 7.69 Million USD | -6462.854% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 1873601.039% |
| InVitro International | -313.14 Thousand USD | 161351.445% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -32146.088% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 70820015.849% |
| Medical Imaging Corp. | 3.79 Million USD | -13219.827% |
| NovelStem International Corp. | 3.52 Million USD | -14238.8% |
| Optigenex Inc. | 8.93 Million USD | -5551.973% |
| PharmChem, Inc. | -1.49 Million USD | 33888.919% |
| Proteome Sciences plc | 14.57 Million USD | -3364.87% |
| Response Genetics, Inc | -13.08 Million USD | 3958.673% |
| Rennova Health, Inc. | 14.82 Million USD | -3304.924% |
| RushNet, Inc. | 4.8 Million USD | -10417.857% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -372309.266% |
| Stella Diagnostics Inc. | 6.19 Million USD | -8053.418% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -28197.819% |
| Todos Medical Ltd. | 38.31 Million USD | -1217.915% |